Pharma Gets 340B Appeals Court Victory But More Decisions Are Pending; Will Congress Step In?

Third Circuit is first of three federal appeals courts to issue a decision in multiple lawsuits over drug companies’ 340B contract pharmacy restrictions, which have led to conflicting lower court rulings on whether such restrictions are unlawful.

Legal Disputes Over Safety Net Program Beginning To Resolve? • Source: Shutterstock

Pharmaceutical manufacturers won a significant federal appeals court decision on 30 January in the ongoing legal dispute with the US Department of Health and Human Services regarding whether they can restrict 340B drug discounts to contract pharmacies.

The US Court of Appeals for the Third Circuit

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access